Ubelgiji - Kiholanzi - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

astellas pharma bv-srl - tamsulosinehydrochloride 0,4 mg - filmomhulde tablet met verlengde afgifte - 0,4 mg - tamsulosinehydrochloride 0.4 mg - tamsulosin

Ubelgiji - Kiholanzi - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - tamsulosinehydrochloride 0,4 mg - capsule met gereguleerde afgifte, hard - 0,4 mg - tamsulosinehydrochloride 0.4 mg - tamsulosin

Ubelgiji - Kiholanzi - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - tamsulosinehydrochloride 0,4 mg - capsule met gereguleerde afgifte, hard - 0,4 mg - tamsulosinehydrochloride 0.4 mg - tamsulosin

Uholanzi - Kiholanzi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

apotex europe bv archimedesweg 2 2333 cn leiden - gemfibrozil 600 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat ; polyethyleenglycol (e 1521) ; polysorbaat 80 (e 433) ; siliciumdioxide (e 551) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat ; polyethyleenglycol (e 1521) ; polysorbaat 80 (e 433) ; siliciumdioxide (e 551) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; hypromellose (e 464) ; magnesiumstearaat (e 470b) ; maÏszetmeel ; natriumzetmeelglycolaat (e468) ; polyethyleenglycol (e 1521) ; polysorbaat 80 (e 433) ; siliciumdioxide (e 551) ; titaandioxide (e 171), - gemfibrozil

Uholanzi - Kiholanzi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

apotex europe bv archimedesweg 2 2333 cn leiden - prednison 5 mg/stuk - tablet - lactose 1-water ; magnesiumstearaat (e 470b) ; maÏszetmeel ; povidon k 25 (e 1201) ; talk (e 553 b), - prednisone

Umoja wa Ulaya - Kiholanzi - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressiva - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant.

Umoja wa Ulaya - Kiholanzi - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - ophthalmologica - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Umoja wa Ulaya - Kiholanzi - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Umoja wa Ulaya - Kiholanzi - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - ophthalmologica - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Uholanzi - Kiholanzi - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

sandoz b.v. veluwezoom 22 1327 ah almere - omeprazol magnesium 20,6 mg/stuk samenstelling overeenkomend met ; omeprazol 20 mg/stuk - maagsapresistente tablet - cellulose, microkristallijn (e 460(i)) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; copovidon (e 1208) ; crospovidon (e 1202) ; dimeticon (e 900) ; glucose, vloeibaar ; glycerolmonostearaat 40-55 (e 471) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polysorbaat 80 (e 433) ; povidon k 25 (e 1201) ; propyleenglycol (e 1520) ; saccharose ; siliciumdioxide (e 551) ; siliciumdioxide, gehydrateerd (e 551) ; stearinezuur (e 570) ; suikermaÏsbolletjes ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; copovidon ; crospovidon (e 1202) ; dimeticon (e 900) ; glucose, vloeibaar ; glycerolmonostearaat 40-55 (e 471) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polysorbaat 80 (e 433) ; povidon k 25 (e 1201) ; propyleenglycol (e 1520) ; saccharose ; siliciumdioxide (e 551) ; siliciumdioxide, gehydrateerd (e 551) ; stearinezuur (e 570) ; suikermaÏsbolletjes ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; copolymeer van ethylacrylaat-methacrylzuur (1:1) ; copovidon ; crospovidon (e 1202) ; dimeticon (e 900) ; glucose, vloeibaar ; glycerolmonostearaat 40-55 (e 471) ; hypromellose (e 464) ; ijzeroxide rood (e 172) ; macrogol 6000 ; magnesiumstearaat (e 470b) ; maÏszetmeel ; polysorbaat 80 (e 433) ; povidon k 25 (e 1201) ; propyleenglycol (e 1520) ; saccharose ; siliciumdioxide (e 551) ; siliciumdioxide, gehydrateerd (e 551) - omeprazole